Moderna vaccine trial pleases investors, EBIT...

Google said it plans to spend at least $55bn more on capital expenditure this year than Wall Street had forecast, US tech stocks were hit by a fresh wave of selling on Wednesday, and the FT’s Chris Cook talks about the challenges of unpacking millions of documents on Jefferey Eps ...  Show more

US tech stocks fell on Tuesday over AI concerns, Elon Musk is charting a new path for his “Muskverse” of companies, and the US military shot down an Iranian drone as Middle East tensions escalate. Plus, domestic energy companies in Argentina have benefitted from the country’s vol ...  Show more

The Taliban’s takeover is a boon for China’s propaganda machine: America is tired, its policies disastrous, its values a distraction. Meanwhile China has <a href="https://www.economist.com/china/2021/08/21/china-is-happy-to-see-america-humbled-in-afghanistan?utm_campaign=the-i ...

Show Notes:

0:00 Quick vaccine passports update

17:15 China's massive tech crackdown: reasons, ramifications, & more

37:37 How will large firms & institutional investors react to the CCP's recent regulatory moves, mechanics of delisting public companies

The FT News Briefing is a rundown of the global business stories you need to know for the coming day, from the newsroom of the Financial Times. If you enjoy it, subscribe to the FT News Briefing wherever you get your podcasts, or listen at FT.com/newsbriefing.Friday, March 20Repu ...  Show more

With astonishing speed, the machinery of testing, tracing and lockdowns is being dismantled. We examine the <a href="https://www.economist.com/leaders/2022/12/07/china-is-loosening-its-covid-restrictions-at-great-risk?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=thein ...  Show more